Dec 22, 2022 | Teresa Miceli
Attending the 64th American Society of Hematology (ASH) Annual Meeting, I am continually reminded of how far we have come in the treatment landscape of multiple myeloma (MM) since I became a nurse I 1991. Acronyms of drug regimens that, for the most part, are no...
Dec 1, 2022 | Linda Huguelet
I’m in my 12th year as a myeloma patient, and this is my 10th year to attend the American Society of Hematology (ASH) Conference. I was reminded of my first ASH recently when I placed a red origami bird, from the Takeda Oncology exhibit booth in 2013, on my Christmas...
